Blockade of kappa opioid receptors reduces mechanical hyperalgesia and anxiety-like behavior in a rat model of trigeminal neuropathic pain.

Abstract

It has been shown that kappa opioid receptor (KOR) antagonists, such as nor-binaltorphimine (nor-BNI), have antinociceptive effects in some pain models that affect the trigeminal system. Also, its anxiolytic-like effect has been extensively demonstrated in the literature. The present study aimed to investigate the systemic, local, and central effect of nor-BNI on trigeminal neuropathic pain using the infraorbital nerve constriction model (CCI-ION), as well as to evaluate its effect on anxiety-like behavior associated with this model. Animals received nor-BNI systemically; in the trigeminal ganglion (TG); in the subarachnoid space to target the spinal trigeminal nucleus caudalis (Sp5C) or in the central amygdala (CeA) 14 days after CCI-ION surgery. Systemic administration of nor-BNI caused a significant reduction of facial mechanical hyperalgesia and promoted an anxiolytic-like effect, which was detected in the elevated plus-maze and the light-dark transition tests. When administered in the TG or CeA, the KOR antagonist was able to reduce facial mechanical hyperalgesia induced by CCI-ION, but without changing the anxiety-like behavior. Moreover, no change was observed on nociception and anxiety-like behavior after nor-BNI injection into the Sp5C. The present study demonstrated antinociceptive and anxiolytic-like effects of nor-BNI in a model of trigeminal neuropathic pain. The antinociceptive effect seems to be dissociated from the anxiolytic-like effect, at both the sites involved and at the dose need to achieve the effect. In conclusion, the kappa opioid system may represent a promising target to be explored for the control of trigeminal pain and associated anxiety. However, further studies are necessary to better elucidate its functioning and modulatory role in chronic trigeminal pain states.

• Authors: Joelle de Melo Turnes, Erika Ivanna Araya, Amanda Ribeiro Barroso, Darciane Favero Baggio, Laura de Oliveira Koren, Janaína Menezes Zanoveli, Juliana Geremias Chichorro
• Journal: Behavioural brain research (Behav Brain Res) Vol. 417 Pg. 113595 (01 24 2022) ISSN: 1872-7549 [Electronic] Netherlands
• PMID: 34592375 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021. Published by Elsevier B.V.

Chemical References

• Receptors, Opioid, kappa
• norbinaltorphimine
• Naltrexone

Topics

• Animals
• Anxiety (drug therapy)
• Central Amygdaloid Nucleus (drug effects)
• Chronic Pain (complications)
• Disease Models, Animal
• Hyperalgesia (drug therapy)
• Male
• Naltrexone (analogs & derivatives, pharmacology)
• Nociception (drug effects)
• Rats
• Rats, Sprague-Dawley
• Receptors, Opioid, kappa (antagonists & inhibitors)
• Trigeminal Neuralgia (complications)